Bio-Modeling Systems is the world’s first Mechanisms-Based Medicine company that successfully changed the discovery paradigm, addressing the complexity of life sciences mechanisms and the digital « garbage in garbage out » reality through CADI*™ Discovery.
We offer to R&D & Translational Medicine Executives, robust alternative decision-making to de-risk, save time, costs, and novel cost-effective diagnostics/therapies for their businesses.
Created in 2004, profitable since 2006, thanks to our recurrent clients, we already confirmed in Pharma, Biotech, Cosmetics, Nutrition and digital-Health, CADI™ Discovery capability to achieve:
A world's first in neurodegenerative diseases (publication) with CEA: 2 awards (US & Europe).
Pherecydes-Pharma: First BMSystems' therapeutic spin-off,against MR infections therapies, 3 patents, publication, world's first clinical trial with bacteriophages in Phase I/II, Compassionate Use Success.
CEA/BMSystems collaborative research in CNS that led to the co-owned patent with a worldwide exclusive license to Theranexus, CEA’s spin-off currently in Phase II,
Latest news: BMSystems is the Integrative Biology partner of GEMMA (Genome, Environment, Microbiome and Metabolome in Autism) project with €14.2M H2020 funding
We warmly invite you to download our management summary, our Short corporate Presentation or our CADI™ Discovery Concept and POCs Presentation.
*Computer Augmented Deductive Intelligence platform.
The life-modeling issue: Are we using the right concepts in the righ order?
CADI™ : Computer Augmented Deductive Intelligence)